2 September 2019 - Stroke patients and those who have suffered traumatic brain or spinal cord injuries will save thousands of dollars for Botox through the Pharmaceutical Benefits Scheme, to treat involuntary muscle movements, or spasticity, in their lower limbs.

Hundreds of thousands of Australians will suffer the effects of stroke, with more than a third (38 per cent) of survivors suffering spasticity within 12 months, while 80 per cent of those with spinal cord injury also suffering spasticity.

Allergan, which produces Botox, says inclusion of the treatment on the PBS for adult stroke and brain injury patients will "help support the management of their symptoms, quality of life and reduce the burden of disease".

Read The West Australian article